Trial Profile
Open-label, randomised, two-period and two-treatment crossover study evaluating the pharmacokinetics and bioequivalence of sildenafil granules and sildenafil tablets in Korean healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 May 2014
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors SAMA Pharmaceuticals
- 07 May 2014 New trial record
- 30 Apr 2014 Results published in the International Journal of Clinical Pharmacology and Therapeutics.